Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biomerica Inc (BMRA)

Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,455
  • Shares Outstanding, K 16,822
  • Annual Sales, $ 5,420 K
  • Annual Income, $ -5,980 K
  • EBIT $ -7 M
  • EBITDA $ -6 M
  • 60-Month Beta -1.13
  • Price/Sales 0.99
  • Price/Cash Flow N/A
  • Price/Book 1.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.08 on 10/15/24
  • Next Earnings Date 10/17/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2800 +15.54%
on 10/25/24
0.4354 -25.70%
on 10/30/24
-0.0015 (-0.46%)
since 10/21/24
3-Month
0.2799 +15.58%
on 09/23/24
0.5100 -36.57%
on 08/27/24
-0.1118 (-25.68%)
since 08/21/24
52-Week
0.2415 +33.95%
on 08/05/24
2.1300 -84.81%
on 12/18/23
-0.5265 (-61.94%)
since 11/21/23

Most Recent Stories

More News
Biomerica Secures European Patent Approvals for inFoods® Technology Targeting Multi-Billion-Dollar Gastrointestinal Markets

Biomerica receives European patents for inFoods® technology targeting GERD, Crohn’s Disease, and Ulcerative Colitis, tapping into significant market potential.Quiver AI SummaryBiomerica, Inc. has announced...

BMRA : 0.3235 (-0.25%)
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

BMRA : 0.3235 (-0.25%)
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

BMRA : 0.3235 (-0.25%)
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

BMRA : 0.3235 (-0.25%)
Biomerica Reports First Quarter Fiscal 2025 Financial Results

BMRA : 0.3235 (-0.25%)
Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam

Simple at-home device to increase sensitivity in breast self examsEarly detection of breast cancer saves livesBreast Cancer accounts for 1 in 3 new cases...

BMRA : 0.3235 (-0.25%)
Biomerica to Participate at BTIG Biotech Conference

IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that the Company’s CEO will participate at the 2022 BTIG...

BMRA : 0.3235 (-0.25%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 3.37 (-0.88%)
LPTH : 1.5000 (unch)
RCAT : 7.30 (+14.60%)
IONM : 0.0587 (+30.73%)
PYR : 0.3799 (unch)
OSS : 2.44 (+4.72%)
MODD : 1.94 (-5.83%)
STRN : 1.3400 (+0.75%)
AEYE : 25.24 (+0.94%)
SMFL : 0.0450 (-2.17%)
LFMD : 5.69 (+4.98%)
SURG : 1.8000 (+23.29%)
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

- Attaining CE Mark is a major step toward commercialization – - World Health Organization (WHO) lists H. pylori among the 16 antibiotic-resistant...

BMRA : 0.3235 (-0.25%)
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial...

BMRA : 0.3235 (-0.25%)

Business Summary

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include...

See More

Key Turning Points

3rd Resistance Point 0.3750
2nd Resistance Point 0.3575
1st Resistance Point 0.3405
Last Price 0.3235
1st Support Level 0.3060
2nd Support Level 0.2885
3rd Support Level 0.2715

See More

52-Week High 2.1300
Fibonacci 61.8% 1.4086
Fibonacci 50% 1.1858
Fibonacci 38.2% 0.9629
Last Price 0.3235
52-Week Low 0.2415

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar